Personal Health  
comments_image Comments

6 New Ways Big Pharma Is Scheming to Make Billions at the Expense of Your Health

With many of Big Pharma's biggest hits going off patent, the industry is looking for new ways to deliver earnings to Wall Street.

Continued from previous page

 
 
Share
 
 
 

To sell Neurontin, Pfizer's Parke-Davis launched an elaborate "publication plan" to get marketing papers disguised as science in medical journals. In just three years, Parke-Davis planted  13 ghostwritten articles in medical journals promoting off-label uses for Neurontin including a supplement to the prestigious  Cleveland Clinic Journal of Medicine that Parke-Davis made into 43,000 reprints for its reps to disseminate. See Doc, it says right here....

And there was more duplicity. In 2011, three years after its $430 million settlement, Pfizer's STEPS trial (“Study of Neurontin: Titrate to Effect, Profile of Safety”)  was reported to also be a con and not a scientific study; it was a sales tool created to inspire the 772 investigators participating in the trail to personally prescribe Neurontin. Recently, the new uses of Neurontin for chronic cough, menopause and insomnia are appearing in scientific literature. Why does no one seem to believe them?

Martha Rosenberg is an investigative health reporter and the author of "Born With a Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Random House)."

 
See more stories tagged with: